#efta00599646
LightNews LightNews
epsteinweb.bsky.social
Parts 1-2/2 — EFTA00599646.jpg
#epsteinweb #efta00599646
https://epsteinweb.org
Available in the iOS app store now!
https://apps.apple.com/us/app/epstein-web/id6758880661
EFTA00599643 | EFTA00599646 BioReference n —s PRELIMINARY LABORATORIES FISCH, HARRY D 0 C1720 - HARRY FISCH, M.D. C T NEW YORK, NY 10028 R Acct #: (C1720) P: EPSTEIN, JEFFREY p DOB: 21/20/1953 Age: 63 y Sex: M A U/FL: Bed: T Rm: I Patient ID: E Address:9 EAST 715T STREET, N NEW YORK, NY 10021 T P: (212)772-9416 Si Specimen ID: 102449709 Date Of Report: 01/28/2016 02:32 Date Collected: 01/27/2016 12:37 Date Received: 01/27/2016 23:01 1 North America Eastern Time CLINICAL REPORT e erence Test Result Abnormal NOTE: Results cannot be interpreted as absolute evidence of the presence or absence of malignant disease. Values obtained with different assay methods or kits cannot be used interchangeably. n s rev ous esu a e ASSAY INFORMATION: Method Electrochemiluminescence Immunoassay (Roche Diagnostics). % FREE PSA 47 See Below % 36 10/27/2015 112.3 LO 74.6 10/27/2015 10/27/2015 FREE PSA RISK ASSESSMENT The probability of prostate cancer for men with non-suspicious DRE results, by age group, using PSA values between 4.000 and 10.000 ng/mL and percent FREE PSA values is summarized in the table below: PROBABILITY OF CANCER* %free PSA (50-59 yrs) (60-69 yrs) (>or.70 yrs) <or-t0 49.2% 57.5% 64.5% 11-18 26.9% 33.9% 40.8% 19-25 18.3% 23.9% 29.7% >25 9.1% 12.2% 15.8% *probability of finding prostate cancer by needle biopsy NOTE: Calculation of percent FREE PSA may not be possible when the value for TOTAL PSA is in the low normal range. These guidelines are for assays performed using the Roche E170 immunoassay system.(02/2012;v5) TESTOSTERONE, TOT.,S. TESTOSTERONE, BIOAVAIL. 296.0 183.8 193.0-740.0 72.0-460.0 ng/dL ng/dL SEX HORM.BIND.GLOB. 18 10-57 nmol/L 14 10/27/2015 FREE TESTOSTERONE LH 80.18 6.8 pg/mL mIU/mL 29.82 LO 3.7 10/27/2015 10/27/2015 FSH 6.8 30.00-150.00 1.7-8.6 1.5-12.4 mIU/mL 4.8 10/27/2015 4.0-15.2 ng/mL 3.4 LO 10/27/2015 7.02-49.06 176-441 pg/mL mg/dL 16.00 362 10/27/2015 10/27/2015 <5.7 % 5.9 HI 10/27/2015 PROLACTIN, SERUM 3.0 LO ESTRADIOL FIBRINOGEN 48.93 276 Hemoglobin A1C 6.0 HI HEMOGLOBIN A1c AND eAG REFERENCE RANGES A1c(%) <5.7 5.7-6.4 .>6.5 DIABETES CATEGORY* Normal (non-diabetic) Increased risk of diabetes Consistent with diabetes A1c(%) eAG(ESTIMATED AVERAGE PLASMA GLUCOSE)(mg/dL) BioReference Laboratories, Inc. Elmwood Park, NJ 07407 I Page 4 of 5 James Weisberger M.D. Laboratory Director Printed 01/28/2016 15:30 EFTA00599646
May 4, 2026 at 11:38 AM